data_2fxp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fxp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.548 -0.221 . . . . 12.45 112.548 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 t -174.93 -74.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 11.51 110.925 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -88.39 88.9 7.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 8.85 110.854 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.404 ' OG1' ' CD2' ' B' ' 3' ' ' HIS . 4.1 m -102.87 159.65 15.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 7.92 110.938 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.5 p -127.31 138.99 33.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 5.23 110.894 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.67 -165.1 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.582 2.188 . . . . 3.84 112.177 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -87.03 111.96 21.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 5.18 110.542 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 8.8 p -91.17 92.03 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 3.32 111.341 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -94.41 98.19 10.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.527 . . . . 3.95 110.419 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HB2' ' HB ' ' B' ' 13' ' ' ILE . 1.5 pp -78.05 -31.48 50.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.358 -0.383 . . . . 3.81 111.038 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.84 -12.81 82.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.602 -0.808 . . . . 2.07 112.665 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -103.81 -44.36 5.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.697 0.284 . . . . 3.34 111.277 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' C' ' 10' ' ' LEU . 1.4 pp -56.43 -32.82 37.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.344 . . . . 2.3 111.403 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -69.29 -76.96 0.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.296 -0.411 . . . . 1.95 110.658 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.96 5.7 53.57 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.01 -0.614 . . . . 1.5 112.992 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.404 ' CG2' HD13 ' C' ' 16' ' ' ILE . 2.6 pp -96.18 -17.77 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.743 0.271 . . . . 2.57 111.523 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -48.77 -49.57 37.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.913 0.387 . . . . 3.23 110.88 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.93 71.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 2.21 110.701 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.3 m -72.55 -40.86 66.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 2.14 110.681 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 t -56.8 -49.13 79.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 2.19 110.928 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 t -63.15 -41.21 91.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 2.7 110.651 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.45 -51.31 69.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 2.73 110.988 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 24' ' ' GLN . 7.0 tp -60.87 -35.39 64.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.303 -0.408 . . . . 2.2 110.61 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.409 ' N ' HG23 ' A' ' 23' ' ' ILE . 28.0 tt0 -61.5 -52.87 62.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 2.56 110.167 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -23.78 67.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.945 -0.571 . . . . 5.12 110.364 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.11 -51.85 49.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 2.4 110.211 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -57.47 -42.67 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.803 -0.443 . . . . 1.43 109.803 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 27' ' ' ILE . 0.4 OUTLIER -54.04 -34.39 59.87 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.879 -0.786 . . . . 2.24 108.879 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -65.87 -36.8 84.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.319 -0.855 . . . . 4.23 109.994 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.526 ' O ' HG12 ' A' ' 33' ' ' VAL . 13.4 mt -79.62 -41.78 26.3 Favored 'General case' 0 CA--C 1.523 -0.073 0 N-CA-C 110.003 -0.369 . . . . 1.36 110.003 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -46.91 54.96 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.401 -0.592 . . . . 2.42 109.401 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -70.27 -33.42 71.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.43 -0.804 . . . . 2.9 109.343 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -60.62 -41.1 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 115.905 -0.589 . . . . 1.7 109.907 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.54 ' N ' HG12 ' A' ' 33' ' ' VAL . . . -67.24 -34.2 76.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.513 -0.551 . . . . 1.23 109.513 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -60.24 -48.9 79.77 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.723 -0.671 . . . . 3.42 110.345 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.81 -38.84 92.6 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.233 -0.654 . . . . 2.58 109.233 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 34.1 mt -62.45 -47.92 81.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.629 -0.878 . . . . 1.45 108.629 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.562 ' HA ' ' HG ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -54.12 -32.39 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.118 -0.947 . . . . 2.2 110.801 178.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' O ' HG13 ' A' ' 42' ' ' ILE . 5.1 tt0 -62.21 -57.04 12.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.899 -0.591 . . . . 2.62 110.034 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.461 ' CB ' ' HB3' ' C' ' 41' ' ' LEU . 12.5 m -52.96 -31.11 38.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.327 0.584 . . . . 1.69 109.928 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.646 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -71.41 -25.56 62.39 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.688 -0.687 . . . . 1.36 110.281 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.506 HG13 ' N ' ' A' ' 43' ' ' ASP . 1.0 OUTLIER -67.53 -31.86 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.795 -1.187 . . . . 2.6 107.795 177.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.506 ' N ' HG13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -61.38 -58.95 6.16 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.798 -1.092 . . . . 1.8 109.966 178.108 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 41' ' ' LEU . 4.2 pp -53.47 -32.74 51.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.195 -0.457 . . . . 2.35 110.586 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -62.61 -38.6 90.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 3.18 110.141 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -84.61 -29.89 25.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.887 -0.597 . . . . 2.91 110.52 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt -58.15 -34.82 70.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 1.62 110.707 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.89 9.12 63.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.749 -0.738 . . . . 1.4 112.847 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -99.26 -74.75 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 4.19 111.199 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -100.18 -36.15 9.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.113 -0.494 . . . . 6.12 111.169 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -52.88 -31.87 41.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 4.97 111.326 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.94 15.01 21.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.451 -0.341 . . . . 4.94 111.394 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -59.94 -24.14 64.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.874 0.369 . . . . 6.99 110.78 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.0 pt -71.38 130.74 35.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 4.63 111.022 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.196 -0.907 . . . . 9.55 110.905 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.521 -0.232 . . . . 12.45 112.521 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -174.89 -74.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 11.51 110.891 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . 0.404 ' CD2' ' OG1' ' A' ' 4' ' ' THR . 21.3 m-70 -88.41 88.83 7.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 8.85 110.819 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.403 ' OG1' ' CD2' ' C' ' 3' ' ' HIS . 4.0 m -102.75 159.62 15.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 7.92 110.957 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.5 p -127.3 139.0 33.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 5.23 110.945 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.7 -165.05 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.542 2.161 . . . . 3.84 112.193 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -87.07 111.99 21.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 5.18 110.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -91.25 92.06 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.057 0.456 . . . . 3.32 111.307 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -94.42 98.24 10.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 3.95 110.368 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 pp -78.05 -31.47 50.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 3.81 111.076 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.87 -12.88 82.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.66 -0.781 . . . . 2.07 112.576 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -103.75 -44.36 5.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.717 0.294 . . . . 3.34 111.283 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 1.4 pp -56.49 -32.79 37.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.416 -0.356 . . . . 2.3 111.397 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -69.28 -76.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 1.95 110.655 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.95 5.73 53.66 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.016 -0.612 . . . . 1.5 112.986 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.407 HD13 ' CG2' ' C' ' 16' ' ' ILE . 2.6 pp -96.14 -17.87 6.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.764 0.282 . . . . 2.57 111.544 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -48.72 -49.57 37.51 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.846 0.355 . . . . 3.23 110.89 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.96 71.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 2.21 110.712 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 67.4 m -72.48 -40.9 66.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.083 -0.508 . . . . 2.14 110.662 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 t -56.8 -49.14 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.445 . . . . 2.19 110.878 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 30.0 t -63.23 -41.13 91.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 2.7 110.572 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.55 -51.32 69.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 2.73 110.916 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.412 HG23 ' N ' ' B' ' 24' ' ' GLN . 6.9 tp -60.9 -35.31 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.315 -0.402 . . . . 2.2 110.633 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.412 ' N ' HG23 ' B' ' 23' ' ' ILE . 28.0 tt0 -61.55 -52.85 62.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 2.56 110.144 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -23.82 67.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 5.12 110.413 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.05 -51.87 49.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 2.4 110.285 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' B' ' 28' ' ' ASP . 1.0 OUTLIER -57.46 -42.67 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.752 -0.462 . . . . 1.43 109.752 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.404 ' N ' ' CG2' ' B' ' 27' ' ' ILE . 0.4 OUTLIER -54.03 -34.4 59.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.852 -0.796 . . . . 2.24 108.852 178.229 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -65.84 -36.92 84.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.328 -0.851 . . . . 4.23 109.943 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.52 ' O ' HG12 ' B' ' 33' ' ' VAL . 13.4 mt -79.57 -41.85 26.3 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.991 -0.374 . . . . 1.36 109.991 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.09 -47.01 54.02 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.373 -0.603 . . . . 2.42 109.373 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -70.2 -33.53 71.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.429 -0.805 . . . . 2.9 109.357 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.54 HG12 ' N ' ' B' ' 34' ' ' ALA . 0.4 OUTLIER -60.52 -41.1 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.905 -0.589 . . . . 1.7 109.964 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.54 ' N ' HG12 ' B' ' 33' ' ' VAL . . . -67.25 -34.18 76.91 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.498 -0.556 . . . . 1.23 109.498 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -60.32 -48.89 79.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.769 -0.651 . . . . 3.42 110.35 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.82 -38.82 92.51 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.209 -0.663 . . . . 2.58 109.209 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.584 ' O ' ' HG ' ' B' ' 41' ' ' LEU . 34.0 mt -62.49 -47.89 82.0 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.597 -0.89 . . . . 1.45 108.597 178.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ASN . . . . . 0.563 ' HA ' ' HG ' ' B' ' 41' ' ' LEU . 0.1 OUTLIER -54.11 -32.44 55.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.151 -0.931 . . . . 2.2 110.749 178.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.431 ' O ' HG13 ' B' ' 42' ' ' ILE . 5.1 tt0 -62.22 -57.07 12.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 2.62 110.016 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 41' ' ' LEU . 12.5 m -52.92 -31.06 38.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.306 0.574 . . . . 1.69 109.977 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.64 ' O ' ' HG ' ' B' ' 44' ' ' LEU . 0.5 OUTLIER -71.44 -25.58 62.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.717 -0.674 . . . . 1.36 110.259 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.504 HG13 ' N ' ' B' ' 43' ' ' ASP . 1.0 OUTLIER -67.51 -31.91 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.744 -1.206 . . . . 2.6 107.744 177.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.504 ' N ' HG13 ' B' ' 42' ' ' ILE . 0.1 OUTLIER -61.39 -58.93 6.24 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 114.798 -1.092 . . . . 1.8 109.979 178.118 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 4.2 pp -53.4 -32.79 51.17 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.236 -0.438 . . . . 2.35 110.603 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . 0.403 ' N ' ' CD1' ' B' ' 44' ' ' LEU . 5.8 mt-30 -62.6 -38.55 90.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 3.18 110.137 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -84.69 -29.83 25.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.842 -0.617 . . . . 2.91 110.505 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt -58.17 -34.87 70.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.035 -0.53 . . . . 1.62 110.682 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.86 9.12 63.8 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.777 -0.725 . . . . 1.4 112.797 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -99.29 -74.75 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.893 0.378 . . . . 4.19 111.176 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -100.21 -36.16 9.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.142 -0.481 . . . . 6.12 111.14 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -52.83 -31.87 41.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 4.96 111.327 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.98 15.0 21.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.431 -0.35 . . . . 4.94 111.34 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -59.95 -24.11 64.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.802 0.334 . . . . 6.99 110.775 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 7.0 pt -71.39 130.69 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 4.63 111.007 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 9.55 110.911 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.493 -0.243 . . . . 12.45 112.493 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -174.91 -74.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 11.51 110.879 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' HIS . . . . . 0.403 ' CD2' ' OG1' ' B' ' 4' ' ' THR . 21.4 m-70 -88.43 88.89 7.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 8.85 110.844 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 4.1 m -102.84 159.62 15.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 7.92 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 19.6 p -127.27 138.97 33.88 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 5.23 110.948 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.64 -165.05 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.568 2.179 . . . . 3.84 112.207 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -87.13 111.99 21.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 5.18 110.504 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' C' ' 8' ' ' VAL . 8.7 p -91.18 92.01 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 3.32 111.341 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -94.39 98.2 10.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.007 -0.542 . . . . 3.95 110.394 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 13' ' ' ILE . 1.5 pp -78.02 -31.47 50.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.309 -0.405 . . . . 3.81 111.072 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.88 -12.81 82.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.64 -0.791 . . . . 2.07 112.612 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -103.82 -44.35 5.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.64 0.257 . . . . 3.34 111.219 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -56.43 -32.85 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.776 0.322 . . . . 2.3 111.399 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -69.26 -77.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 1.95 110.651 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.98 5.73 53.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.98 -0.628 . . . . 1.5 113.026 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.407 ' CG2' HD13 ' B' ' 16' ' ' ILE . 2.6 pp -96.18 -17.87 6.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.753 0.277 . . . . 2.57 111.522 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -48.71 -49.53 37.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.862 0.363 . . . . 3.23 110.902 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -30.88 71.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 2.21 110.706 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 67.3 m -72.55 -40.85 66.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 2.14 110.671 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.82 -49.13 79.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 2.19 110.923 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 30.0 t -63.19 -41.2 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 2.7 110.641 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.45 -51.28 69.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.972 -0.558 . . . . 2.73 110.964 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . 0.402 HG23 ' N ' ' C' ' 24' ' ' GLN . 6.9 tp -60.93 -35.3 63.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.318 -0.401 . . . . 2.2 110.625 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' GLN . . . . . 0.402 ' N ' HG23 ' C' ' 23' ' ' ILE . 28.0 tt0 -61.57 -52.81 62.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 2.56 110.145 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -23.78 67.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.569 . . . . 5.12 110.425 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.12 -51.86 48.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 2.4 110.24 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' C' ' 28' ' ' ASP . 1.0 OUTLIER -57.42 -42.66 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 109.827 -0.434 . . . . 1.43 109.827 179.148 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ASP . . . . . 0.414 ' N ' ' CG2' ' C' ' 27' ' ' ILE . 0.4 OUTLIER -54.07 -34.4 60.02 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.848 -0.797 . . . . 2.23 108.848 178.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -65.85 -36.87 84.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.303 -0.862 . . . . 4.23 109.938 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' LEU . . . . . 0.534 ' O ' HG12 ' C' ' 33' ' ' VAL . 13.3 mt -79.65 -41.84 26.1 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 109.945 -0.391 . . . . 1.36 109.945 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -46.98 53.86 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.404 -0.591 . . . . 2.42 109.404 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -70.24 -33.47 71.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.421 -0.809 . . . . 2.9 109.325 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.535 HG12 ' N ' ' C' ' 34' ' ' ALA . 0.4 OUTLIER -60.61 -41.01 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.926 -0.579 . . . . 1.69 109.973 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' ALA . . . . . 0.535 ' N ' HG12 ' C' ' 33' ' ' VAL . . . -67.24 -34.18 76.91 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.522 -0.548 . . . . 1.23 109.522 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -60.38 -48.83 80.07 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.739 -0.664 . . . . 3.41 110.333 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.76 -38.88 92.75 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.234 -0.654 . . . . 2.57 109.234 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' LEU . . . . . 0.595 ' O ' ' HG ' ' C' ' 41' ' ' LEU . 33.8 mt -62.47 -47.9 81.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.622 -0.881 . . . . 1.45 108.622 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.575 ' HA ' ' HG ' ' C' ' 41' ' ' LEU . 0.1 OUTLIER -54.1 -32.39 54.79 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.146 -0.934 . . . . 2.2 110.811 178.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.441 ' O ' HG13 ' C' ' 42' ' ' ILE . 5.1 tt0 -62.21 -57.08 12.78 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.834 -0.621 . . . . 2.62 110.045 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.461 ' CB ' ' HB3' ' B' ' 41' ' ' LEU . 12.4 m -52.92 -31.1 38.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.987 -0.551 . . . . 1.69 109.922 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' LEU . . . . . 0.631 ' O ' ' HG ' ' C' ' 44' ' ' LEU . 0.5 OUTLIER -71.42 -25.55 62.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.707 -0.679 . . . . 1.36 110.289 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . 0.5 HG13 ' N ' ' C' ' 43' ' ' ASP . 1.0 OUTLIER -67.51 -31.97 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 107.728 -1.212 . . . . 2.6 107.728 177.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.5 ' N ' HG13 ' C' ' 42' ' ' ILE . 0.1 OUTLIER -61.33 -58.94 6.21 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.811 -1.086 . . . . 1.8 109.957 178.14 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' C' ' 41' ' ' LEU . 4.2 pp -53.48 -32.75 51.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.211 -0.449 . . . . 2.35 110.589 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' GLN . . . . . 0.402 ' N ' ' CD1' ' C' ' 44' ' ' LEU . 5.8 mt-30 -62.57 -38.61 90.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 3.18 110.135 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -84.68 -29.78 25.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.602 . . . . 2.91 110.483 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' LEU . . . . . . . . . . . . . 33.0 mt -58.29 -34.82 70.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.107 -0.497 . . . . 1.62 110.641 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.89 9.18 63.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.72 . . . . 1.4 112.81 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -99.31 -74.68 0.58 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.839 0.352 . . . . 4.19 111.216 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -100.2 -36.21 9.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.144 -0.48 . . . . 6.12 111.143 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -52.87 -31.87 41.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 4.96 111.313 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.91 14.95 21.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.428 -0.351 . . . . 4.94 111.363 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -59.87 -24.18 64.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.845 0.355 . . . . 6.99 110.803 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 6.9 pt -71.41 130.73 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 4.63 110.986 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.245 -0.883 . . . . 9.55 110.884 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.548 -0.221 . . . . 12.26 112.548 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 t -174.93 -74.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 11.21 110.925 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.464 ' HB3' HG23 ' C' ' 4' ' ' THR . 23.2 m170 -88.39 88.9 7.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 8.51 110.854 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.448 HG23 ' HB3' ' B' ' 3' ' ' HIS . 4.1 m -102.87 159.65 15.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 7.67 110.938 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.5 p -127.31 138.99 33.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 4.84 110.894 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.67 -165.1 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.582 2.188 . . . . 3.44 112.177 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -87.03 111.96 21.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 5.18 110.542 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 8' ' ' VAL . 8.8 p -91.17 92.03 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 2.8 111.341 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.73 ' O ' HG23 ' A' ' 13' ' ' ILE . 51.2 m-20 -94.41 98.19 10.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.527 . . . . 3.95 110.419 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.713 HD13 ' HB ' ' B' ' 13' ' ' ILE . 1.5 pp -78.05 -31.48 50.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.358 -0.383 . . . . 3.41 111.038 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.84 -12.81 82.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.602 -0.808 . . . . 1.8 112.665 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -103.81 -44.36 5.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.697 0.284 . . . . 3.34 111.277 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.73 HG23 ' O ' ' A' ' 9' ' ' ASP . 1.4 pp -56.43 -32.82 37.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.344 . . . . 1.83 111.403 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -69.29 -76.96 0.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.296 -0.411 . . . . 1.57 110.658 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.96 5.7 53.57 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.01 -0.614 . . . . 1.43 112.992 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.688 HD11 HG12 ' B' ' 16' ' ' ILE . 2.6 pp -96.18 -17.77 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.743 0.271 . . . . 2.04 111.523 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -48.77 -49.57 37.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.913 0.387 . . . . 2.58 110.88 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.93 71.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 1.73 110.701 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.3 m -72.55 -40.86 66.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 1.75 110.681 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 16' ' ' ILE . 15.8 t -56.8 -49.13 79.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 1.66 110.928 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 t -63.15 -41.21 91.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 2.19 110.651 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.45 -51.31 69.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 2.45 110.988 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 20' ' ' VAL . 7.0 tp -60.87 -35.39 64.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.303 -0.408 . . . . 1.65 110.61 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -61.5 -52.87 62.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 2.4 110.167 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -23.78 67.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.945 -0.571 . . . . 4.68 110.364 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.618 ' HB3' HD13 ' C' ' 27' ' ' ILE . 2.1 tt0 -67.11 -51.85 49.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 2.4 110.211 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.888 HD11 ' HA ' ' B' ' 27' ' ' ILE . 1.0 OUTLIER -57.47 -42.67 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.803 -0.443 . . . . 0.93 109.803 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 27' ' ' ILE . 0.4 OUTLIER -54.04 -34.39 59.87 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.879 -0.786 . . . . 2.24 108.879 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -65.87 -36.8 84.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.319 -0.855 . . . . 3.63 109.994 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.718 ' O ' HG12 ' A' ' 33' ' ' VAL . 13.4 mt -79.62 -41.78 26.3 Favored 'General case' 0 CA--C 1.523 -0.073 0 N-CA-C 110.003 -0.369 . . . . 0.95 110.003 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -46.91 54.96 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.401 -0.592 . . . . 2.08 109.401 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -70.27 -33.42 71.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.43 -0.804 . . . . 2.9 109.343 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -60.62 -41.1 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 115.905 -0.589 . . . . 1.2 109.907 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.673 ' HB1' HD11 ' B' ' 37' ' ' LEU . . . -67.24 -34.2 76.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.513 -0.551 . . . . 0.73 109.513 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -60.24 -48.9 79.77 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.723 -0.671 . . . . 3.01 110.345 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.81 -38.84 92.6 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.233 -0.654 . . . . 2.13 109.233 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.671 HD11 ' HB1' ' C' ' 34' ' ' ALA . 34.1 mt -62.45 -47.92 81.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.629 -0.878 . . . . 0.8 108.629 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.586 ' HA ' ' HG ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -54.12 -32.39 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.118 -0.947 . . . . 1.69 110.801 178.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 42' ' ' ILE . 5.1 tt0 -62.21 -57.04 12.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.899 -0.591 . . . . 2.62 110.034 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.544 ' O ' HD22 ' C' ' 44' ' ' LEU . 12.5 m -52.96 -31.11 38.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.327 0.584 . . . . 1.34 109.928 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.768 HD22 ' CD2' ' B' ' 41' ' ' LEU . 0.5 OUTLIER -71.41 -25.56 62.39 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.688 -0.687 . . . . 0.84 110.281 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 43' ' ' ASP . 1.0 OUTLIER -67.53 -31.86 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.795 -1.187 . . . . 2.17 107.795 177.392 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.505 ' N ' HG13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -61.38 -58.95 6.16 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.798 -1.092 . . . . 1.8 109.966 178.108 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.864 HD12 ' N ' ' A' ' 45' ' ' GLN . 4.2 pp -53.47 -32.74 51.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.195 -0.457 . . . . 1.8 110.586 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.864 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.8 mt-30 -62.61 -38.6 90.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 2.69 110.141 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -84.61 -29.89 25.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.887 -0.597 . . . . 2.91 110.52 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.408 HD11 ' O ' ' C' ' 44' ' ' LEU . 33.2 mt -58.15 -34.82 70.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 1.12 110.707 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.89 9.12 63.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.749 -0.738 . . . . 1.4 112.847 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -99.26 -74.75 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 3.87 111.199 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -100.18 -36.15 9.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.113 -0.494 . . . . 5.91 111.169 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 47' ' ' LEU . 2.4 mm-40 -52.88 -31.87 41.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 4.97 111.326 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.94 15.01 21.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.451 -0.341 . . . . 4.36 111.394 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -59.94 -24.14 64.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.874 0.369 . . . . 6.72 110.78 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.681 HD13 ' O ' ' C' ' 54' ' ' ILE . 7.0 pt -71.38 130.74 35.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 4.06 111.022 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HA ' HG21 ' B' ' 54' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.196 -0.907 . . . . 9.19 110.905 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.521 -0.232 . . . . 12.26 112.521 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -174.89 -74.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 11.21 110.891 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' HIS . . . . . 0.448 ' HB3' HG23 ' A' ' 4' ' ' THR . 23.2 m170 -88.41 88.83 7.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 8.51 110.819 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.464 HG23 ' HB3' ' C' ' 3' ' ' HIS . 4.0 m -102.75 159.62 15.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 7.67 110.957 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.5 p -127.3 139.0 33.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 4.84 110.945 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.7 -165.05 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.542 2.161 . . . . 3.44 112.193 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -87.07 111.99 21.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 5.18 110.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.638 ' O ' HG13 ' B' ' 8' ' ' VAL . 8.6 p -91.25 92.06 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.057 0.456 . . . . 2.8 111.307 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ASP . . . . . 0.723 ' O ' HG23 ' B' ' 13' ' ' ILE . 51.1 m-20 -94.42 98.24 10.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 3.95 110.368 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.727 HD13 ' HB ' ' C' ' 13' ' ' ILE . 1.5 pp -78.05 -31.47 50.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 3.41 111.076 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.87 -12.88 82.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.66 -0.781 . . . . 1.8 112.576 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -103.75 -44.36 5.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.717 0.294 . . . . 3.34 111.283 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.723 HG23 ' O ' ' B' ' 9' ' ' ASP . 1.4 pp -56.49 -32.79 37.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.416 -0.356 . . . . 1.83 111.397 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -69.28 -76.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 1.57 110.655 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.95 5.73 53.66 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.016 -0.612 . . . . 1.43 112.986 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.694 HD11 HG12 ' C' ' 16' ' ' ILE . 2.6 pp -96.14 -17.87 6.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.764 0.282 . . . . 2.04 111.544 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -48.72 -49.57 37.51 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.846 0.355 . . . . 2.58 110.89 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.96 71.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 1.73 110.712 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 67.4 m -72.48 -40.9 66.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.083 -0.508 . . . . 1.75 110.662 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.614 HG23 ' O ' ' B' ' 16' ' ' ILE . 15.8 t -56.8 -49.14 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.445 . . . . 1.66 110.878 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 30.0 t -63.23 -41.13 91.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 2.19 110.572 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.55 -51.32 69.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 2.45 110.916 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.504 HG22 ' O ' ' B' ' 20' ' ' VAL . 6.9 tp -60.9 -35.31 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.315 -0.402 . . . . 1.65 110.633 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -61.55 -52.85 62.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 2.4 110.144 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -23.82 67.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 4.68 110.413 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.616 ' HB3' HD13 ' A' ' 27' ' ' ILE . 2.1 tt0 -67.05 -51.87 49.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 2.4 110.285 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.888 ' HA ' HD11 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -57.46 -42.67 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.752 -0.462 . . . . 0.93 109.752 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.404 ' N ' ' CG2' ' B' ' 27' ' ' ILE . 0.4 OUTLIER -54.03 -34.4 59.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.852 -0.796 . . . . 2.24 108.852 178.229 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -65.84 -36.92 84.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.328 -0.851 . . . . 3.63 109.943 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.723 ' O ' HG12 ' B' ' 33' ' ' VAL . 13.4 mt -79.57 -41.85 26.3 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.991 -0.374 . . . . 0.95 109.991 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.09 -47.01 54.02 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.373 -0.603 . . . . 2.08 109.373 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -70.2 -33.53 71.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.429 -0.805 . . . . 2.9 109.357 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.723 HG12 ' O ' ' B' ' 30' ' ' LEU . 0.4 OUTLIER -60.52 -41.1 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.905 -0.589 . . . . 1.2 109.964 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.694 ' HB1' HD11 ' C' ' 37' ' ' LEU . . . -67.25 -34.18 76.91 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.498 -0.556 . . . . 0.73 109.498 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -60.32 -48.89 79.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.769 -0.651 . . . . 3.01 110.35 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.82 -38.82 92.51 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.209 -0.663 . . . . 2.13 109.209 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.673 HD11 ' HB1' ' A' ' 34' ' ' ALA . 34.0 mt -62.49 -47.89 82.0 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.597 -0.89 . . . . 0.8 108.597 178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ASN . . . . . 0.588 ' HA ' ' HG ' ' B' ' 41' ' ' LEU . 0.1 OUTLIER -54.11 -32.44 55.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.151 -0.931 . . . . 1.69 110.749 178.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.457 ' O ' HG13 ' B' ' 42' ' ' ILE . 5.1 tt0 -62.22 -57.07 12.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 2.62 110.016 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.543 ' O ' HD22 ' A' ' 44' ' ' LEU . 12.5 m -52.92 -31.06 38.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.306 0.574 . . . . 1.34 109.977 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.768 ' CD2' HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -71.44 -25.58 62.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.717 -0.674 . . . . 0.84 110.259 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.502 HG13 ' N ' ' B' ' 43' ' ' ASP . 1.0 OUTLIER -67.51 -31.91 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.744 -1.206 . . . . 2.17 107.744 177.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.502 ' N ' HG13 ' B' ' 42' ' ' ILE . 0.1 OUTLIER -61.39 -58.93 6.24 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 114.798 -1.092 . . . . 1.8 109.979 178.118 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.849 HD12 ' N ' ' B' ' 45' ' ' GLN . 4.2 pp -53.4 -32.79 51.17 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.236 -0.438 . . . . 1.8 110.603 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' GLN . . . . . 0.849 ' N ' HD12 ' B' ' 44' ' ' LEU . 5.8 mt-30 -62.6 -38.55 90.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 2.69 110.137 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -84.69 -29.83 25.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.842 -0.617 . . . . 2.91 110.505 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.41 HD11 ' O ' ' A' ' 44' ' ' LEU . 33.2 mt -58.17 -34.87 70.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.035 -0.53 . . . . 1.12 110.682 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.86 9.12 63.8 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.777 -0.725 . . . . 1.4 112.797 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -99.29 -74.75 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.893 0.378 . . . . 3.87 111.176 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -100.21 -36.16 9.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.142 -0.481 . . . . 5.91 111.14 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -52.83 -31.87 41.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 4.96 111.327 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.98 15.0 21.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.431 -0.35 . . . . 4.35 111.34 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -59.95 -24.11 64.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.802 0.334 . . . . 6.72 110.775 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.681 ' O ' HD13 ' C' ' 54' ' ' ILE . 7.0 pt -71.39 130.69 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 4.06 111.007 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.444 ' HA ' HG21 ' C' ' 54' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 9.19 110.911 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.493 -0.243 . . . . 12.26 112.493 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -174.91 -74.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 11.21 110.879 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' HIS . . . . . 0.464 ' HB3' HG23 ' B' ' 4' ' ' THR . 23.2 m170 -88.43 88.89 7.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 8.51 110.844 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 4' ' ' THR . . . . . 0.464 HG23 ' HB3' ' A' ' 3' ' ' HIS . 4.1 m -102.84 159.62 15.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 7.67 110.886 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 19.6 p -127.27 138.97 33.88 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 4.84 110.948 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.64 -165.05 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.568 2.179 . . . . 3.44 112.207 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -87.13 111.99 21.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 5.18 110.504 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' VAL . . . . . 0.655 ' O ' HG13 ' C' ' 8' ' ' VAL . 8.7 p -91.18 92.01 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 2.8 111.341 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' ASP . . . . . 0.735 ' O ' HG23 ' C' ' 13' ' ' ILE . 51.2 m-20 -94.39 98.2 10.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.007 -0.542 . . . . 3.95 110.394 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' LEU . . . . . 0.711 HD13 ' HB ' ' A' ' 13' ' ' ILE . 1.5 pp -78.02 -31.47 50.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.309 -0.405 . . . . 3.41 111.072 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.88 -12.81 82.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.64 -0.791 . . . . 1.8 112.612 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -103.82 -44.35 5.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.64 0.257 . . . . 3.34 111.219 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.735 HG23 ' O ' ' C' ' 9' ' ' ASP . 1.4 pp -56.43 -32.85 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.776 0.322 . . . . 1.83 111.399 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -69.26 -77.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 1.57 110.651 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.98 5.73 53.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.98 -0.628 . . . . 1.42 113.026 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.694 HG12 HD11 ' B' ' 16' ' ' ILE . 2.6 pp -96.18 -17.87 6.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.753 0.277 . . . . 2.04 111.522 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -48.71 -49.53 37.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.862 0.363 . . . . 2.58 110.902 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -30.88 71.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 1.73 110.706 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 67.3 m -72.55 -40.85 66.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 1.75 110.671 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' VAL . . . . . 0.623 HG23 ' O ' ' C' ' 16' ' ' ILE . 15.9 t -56.82 -49.13 79.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 1.66 110.923 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 30.0 t -63.19 -41.2 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 2.19 110.641 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.45 -51.28 69.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.972 -0.558 . . . . 2.45 110.964 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.503 HG22 ' O ' ' C' ' 20' ' ' VAL . 6.9 tp -60.93 -35.3 63.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.318 -0.401 . . . . 1.65 110.625 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -61.57 -52.81 62.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 2.4 110.145 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -23.78 67.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.569 . . . . 4.68 110.425 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 26' ' ' GLU . . . . . 0.6 ' HB3' HD13 ' B' ' 27' ' ' ILE . 2.1 tt0 -67.12 -51.86 48.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 2.4 110.24 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 27' ' ' ILE . . . . . 0.872 ' HA ' HD11 ' B' ' 27' ' ' ILE . 1.0 OUTLIER -57.42 -42.66 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 109.827 -0.434 . . . . 0.93 109.827 179.148 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ASP . . . . . 0.414 ' N ' ' CG2' ' C' ' 27' ' ' ILE . 0.4 OUTLIER -54.07 -34.4 60.02 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.848 -0.797 . . . . 2.23 108.848 178.25 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -65.85 -36.87 84.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.303 -0.862 . . . . 3.63 109.938 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' LEU . . . . . 0.699 ' O ' HG12 ' C' ' 33' ' ' VAL . 13.3 mt -79.65 -41.84 26.1 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 109.945 -0.391 . . . . 0.95 109.945 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -46.98 53.86 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.404 -0.591 . . . . 2.08 109.404 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -70.24 -33.47 71.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.421 -0.809 . . . . 2.9 109.325 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.699 HG12 ' O ' ' C' ' 30' ' ' LEU . 0.4 OUTLIER -60.61 -41.01 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.926 -0.579 . . . . 1.19 109.973 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 34' ' ' ALA . . . . . 0.671 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -67.24 -34.18 76.91 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.522 -0.548 . . . . 0.73 109.522 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -60.38 -48.83 80.07 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.739 -0.664 . . . . 3.01 110.333 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.76 -38.88 92.75 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.234 -0.654 . . . . 2.13 109.234 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' LEU . . . . . 0.694 HD11 ' HB1' ' B' ' 34' ' ' ALA . 33.8 mt -62.47 -47.9 81.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.622 -0.881 . . . . 0.8 108.622 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.597 ' HA ' ' HG ' ' C' ' 41' ' ' LEU . 0.1 OUTLIER -54.1 -32.39 54.79 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.146 -0.934 . . . . 1.69 110.811 178.742 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.468 ' O ' HG13 ' C' ' 42' ' ' ILE . 5.1 tt0 -62.21 -57.08 12.78 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.834 -0.621 . . . . 2.62 110.045 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.547 ' O ' HD22 ' B' ' 44' ' ' LEU . 12.4 m -52.92 -31.1 38.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.987 -0.551 . . . . 1.34 109.922 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 41' ' ' LEU . . . . . 0.767 ' CD2' HD22 ' B' ' 41' ' ' LEU . 0.5 OUTLIER -71.42 -25.55 62.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.707 -0.679 . . . . 0.84 110.289 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 42' ' ' ILE . . . . . 0.502 HG13 ' N ' ' C' ' 43' ' ' ASP . 1.0 OUTLIER -67.51 -31.97 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 107.728 -1.212 . . . . 2.17 107.728 177.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.502 ' N ' HG13 ' C' ' 42' ' ' ILE . 0.1 OUTLIER -61.33 -58.94 6.21 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.811 -1.086 . . . . 1.8 109.957 178.14 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.854 HD12 ' N ' ' C' ' 45' ' ' GLN . 4.2 pp -53.48 -32.75 51.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.211 -0.449 . . . . 1.8 110.589 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' GLN . . . . . 0.854 ' N ' HD12 ' C' ' 44' ' ' LEU . 5.8 mt-30 -62.57 -38.61 90.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 2.69 110.135 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -84.68 -29.78 25.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.602 . . . . 2.91 110.483 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' LEU . . . . . 0.407 HD11 ' O ' ' B' ' 44' ' ' LEU . 33.0 mt -58.29 -34.82 70.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.107 -0.497 . . . . 1.12 110.641 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.89 9.18 63.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.72 . . . . 1.4 112.81 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -99.31 -74.68 0.58 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.839 0.352 . . . . 3.87 111.216 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -100.2 -36.21 9.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.144 -0.48 . . . . 5.91 111.143 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -52.87 -31.87 41.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 4.96 111.313 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.91 14.95 21.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.428 -0.351 . . . . 4.36 111.363 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -59.87 -24.18 64.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.845 0.355 . . . . 6.72 110.803 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ILE . . . . . 0.681 HD13 ' O ' ' B' ' 54' ' ' ILE . 6.9 pt -71.41 130.73 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 4.06 110.986 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' LYS . . . . . 0.442 ' HA ' HG21 ' A' ' 54' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.245 -0.883 . . . . 9.19 110.884 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.548 -0.221 . . . . 12.26 112.548 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 t -174.93 -74.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 11.210000000000001 110.925 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.464 ' HB3' HG23 ' C' ' 4' ' ' THR . 21.2 m-70 -88.39 88.9 7.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 8.5099999999999998 110.854 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.448 HG23 ' HB3' ' B' ' 3' ' ' HIS . 4.1 m -102.87 159.65 15.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 7.6699999999999999 110.938 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.5 p -127.31 138.99 33.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 4.8399999999999999 110.894 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.67 -165.1 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.582 2.188 . . . . 3.4399999999999999 112.177 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -87.03 111.96 21.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 5.1799999999999997 110.542 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 8' ' ' VAL . 8.8 p -91.17 92.03 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 2.7999999999999998 111.341 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.73 ' O ' HG23 ' A' ' 13' ' ' ILE . 51.2 m-20 -94.41 98.19 10.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.527 . . . . 3.9500000000000002 110.419 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.713 HD13 ' HB ' ' B' ' 13' ' ' ILE . 1.5 pp -78.05 -31.48 50.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.358 -0.383 . . . . 3.4100000000000001 111.038 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.84 -12.81 82.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.602 -0.808 . . . . 1.8 112.665 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -103.81 -44.36 5.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.697 0.284 . . . . 3.3399999999999999 111.277 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.73 HG23 ' O ' ' A' ' 9' ' ' ASP . 1.4 pp -56.43 -32.82 37.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.344 . . . . 1.8300000000000001 111.403 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -69.29 -76.96 0.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.296 -0.411 . . . . 1.5700000000000001 110.658 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.96 5.7 53.57 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.01 -0.614 . . . . 1.4299999999999999 112.992 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.688 HD11 HG12 ' B' ' 16' ' ' ILE . 2.6 pp -96.18 -17.77 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.743 0.271 . . . . 2.04 111.523 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -48.77 -49.57 37.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.913 0.387 . . . . 2.5800000000000001 110.88 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.93 71.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 1.73 110.701 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.3 m -72.55 -40.86 66.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 1.75 110.681 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 16' ' ' ILE . 15.8 t -56.8 -49.13 79.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 1.6599999999999999 110.928 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 t -63.15 -41.21 91.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 2.1899999999999999 110.651 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.45 -51.31 69.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 2.4500000000000002 110.988 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 20' ' ' VAL . 7.0 tp -60.87 -35.39 64.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.303 -0.408 . . . . 1.6499999999999999 110.61 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -61.5 -52.87 62.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 2.3999999999999999 110.167 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -23.78 67.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.945 -0.571 . . . . 4.6799999999999997 110.364 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.618 ' HB3' HD13 ' C' ' 27' ' ' ILE . 2.1 tt0 -67.11 -51.85 49.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 2.3999999999999999 110.211 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.888 HD11 ' HA ' ' B' ' 27' ' ' ILE . 1.0 OUTLIER -57.47 -42.67 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.803 -0.443 . . . . 0.93000000000000005 109.803 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 27' ' ' ILE . 0.4 OUTLIER -54.04 -34.39 59.87 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.879 -0.786 . . . . 2.2400000000000002 108.879 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -65.87 -36.8 84.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.319 -0.855 . . . . 3.6299999999999999 109.994 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.718 ' O ' HG12 ' A' ' 33' ' ' VAL . 13.4 mt -79.62 -41.78 26.3 Favored 'General case' 0 CA--C 1.523 -0.073 0 N-CA-C 110.003 -0.369 . . . . 0.94999999999999996 110.003 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -46.91 54.96 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.401 -0.592 . . . . 2.0800000000000001 109.401 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -70.27 -33.42 71.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.43 -0.804 . . . . 2.8999999999999999 109.343 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -60.62 -41.1 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 115.905 -0.589 . . . . 1.2 109.907 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.673 ' HB1' HD11 ' B' ' 37' ' ' LEU . . . -67.24 -34.2 76.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.513 -0.551 . . . . 0.72999999999999998 109.513 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -60.24 -48.9 79.77 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.723 -0.671 . . . . 3.0099999999999998 110.345 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.81 -38.84 92.6 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.233 -0.654 . . . . 2.1299999999999999 109.233 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.671 HD11 ' HB1' ' C' ' 34' ' ' ALA . 34.1 mt -62.45 -47.92 81.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.629 -0.878 . . . . 0.80000000000000004 108.629 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.586 ' HA ' ' HG ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -54.12 -32.39 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.118 -0.947 . . . . 1.6899999999999999 110.801 178.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 42' ' ' ILE . 5.1 tt0 -62.21 -57.04 12.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.899 -0.591 . . . . 2.6200000000000001 110.034 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.544 ' O ' HD22 ' C' ' 44' ' ' LEU . 12.5 m -52.96 -31.11 38.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.327 0.584 . . . . 1.3400000000000001 109.928 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.768 HD22 ' CD2' ' B' ' 41' ' ' LEU . 0.5 OUTLIER -71.41 -25.56 62.39 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.688 -0.687 . . . . 0.83999999999999997 110.281 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 43' ' ' ASP . 1.0 OUTLIER -67.53 -31.86 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.795 -1.187 . . . . 2.1699999999999999 107.795 177.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.505 ' N ' HG13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -61.38 -58.95 6.16 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.798 -1.092 . . . . 1.8 109.966 178.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.864 HD12 ' N ' ' A' ' 45' ' ' GLN . 4.2 pp -53.47 -32.74 51.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.195 -0.457 . . . . 1.8 110.586 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.864 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.8 mt-30 -62.61 -38.6 90.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 2.6899999999999999 110.141 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -84.61 -29.89 25.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.887 -0.597 . . . . 2.9100000000000001 110.52 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.408 HD11 ' O ' ' C' ' 44' ' ' LEU . 33.2 mt -58.15 -34.82 70.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 1.1200000000000001 110.707 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.89 9.12 63.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.749 -0.738 . . . . 1.3999999999999999 112.847 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -99.26 -74.75 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 3.8700000000000001 111.199 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -100.18 -36.15 9.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.113 -0.494 . . . . 5.9100000000000001 111.169 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 47' ' ' LEU . 2.4 mm-40 -52.88 -31.87 41.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 4.9699999999999998 111.326 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.94 15.01 21.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.451 -0.341 . . . . 4.3600000000000003 111.394 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -59.94 -24.14 64.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.874 0.369 . . . . 6.7199999999999998 110.78 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.681 HD13 ' O ' ' C' ' 54' ' ' ILE . 7.0 pt -71.38 130.74 35.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 4.0599999999999996 111.022 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HA ' HG21 ' B' ' 54' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.196 -0.907 . . . . 9.1899999999999995 110.905 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.521 -0.232 . . . . 12.26 112.521 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -174.89 -74.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 11.210000000000001 110.891 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . 0.448 ' HB3' HG23 ' A' ' 4' ' ' THR . 21.3 m-70 -88.41 88.83 7.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 8.5099999999999998 110.819 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.464 HG23 ' HB3' ' C' ' 3' ' ' HIS . 4.0 m -102.75 159.62 15.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 7.6699999999999999 110.957 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.5 p -127.3 139.0 33.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 4.8399999999999999 110.945 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.7 -165.05 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.542 2.161 . . . . 3.4399999999999999 112.193 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -87.07 111.99 21.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 5.1799999999999997 110.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.638 HG13 ' O ' ' B' ' 8' ' ' VAL . 8.6 p -91.25 92.06 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.057 0.456 . . . . 2.7999999999999998 111.307 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . 0.723 ' O ' HG23 ' B' ' 13' ' ' ILE . 51.1 m-20 -94.42 98.24 10.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 3.9500000000000002 110.368 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.727 HD13 ' HB ' ' C' ' 13' ' ' ILE . 1.5 pp -78.05 -31.47 50.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 3.4100000000000001 111.076 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.87 -12.88 82.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.66 -0.781 . . . . 1.8 112.576 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -103.75 -44.36 5.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.717 0.294 . . . . 3.3399999999999999 111.283 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.723 HG23 ' O ' ' B' ' 9' ' ' ASP . 1.4 pp -56.49 -32.79 37.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.416 -0.356 . . . . 1.8300000000000001 111.397 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -69.28 -76.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 1.5700000000000001 110.655 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.95 5.73 53.66 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.016 -0.612 . . . . 1.4299999999999999 112.986 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.694 HD11 HG12 ' C' ' 16' ' ' ILE . 2.6 pp -96.14 -17.87 6.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.764 0.282 . . . . 2.04 111.544 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -48.72 -49.57 37.51 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.846 0.355 . . . . 2.5800000000000001 110.89 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.96 71.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 1.73 110.712 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 67.4 m -72.48 -40.9 66.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.083 -0.508 . . . . 1.75 110.662 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.614 HG23 ' O ' ' B' ' 16' ' ' ILE . 15.8 t -56.8 -49.14 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.445 . . . . 1.6599999999999999 110.878 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 30.0 t -63.23 -41.13 91.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 2.1899999999999999 110.572 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.55 -51.32 69.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 2.4500000000000002 110.916 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.504 HG22 ' O ' ' B' ' 20' ' ' VAL . 6.9 tp -60.9 -35.31 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.315 -0.402 . . . . 1.6499999999999999 110.633 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -61.55 -52.85 62.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 2.3999999999999999 110.144 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -23.82 67.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 4.6799999999999997 110.413 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.616 ' HB3' HD13 ' A' ' 27' ' ' ILE . 2.1 tt0 -67.05 -51.87 49.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 2.3999999999999999 110.285 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.888 ' HA ' HD11 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -57.46 -42.67 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.752 -0.462 . . . . 0.93000000000000005 109.752 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.404 ' N ' ' CG2' ' B' ' 27' ' ' ILE . 0.4 OUTLIER -54.03 -34.4 59.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.852 -0.796 . . . . 2.2400000000000002 108.852 178.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -65.84 -36.92 84.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.328 -0.851 . . . . 3.6299999999999999 109.943 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.723 ' O ' HG12 ' B' ' 33' ' ' VAL . 13.4 mt -79.57 -41.85 26.3 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.991 -0.374 . . . . 0.94999999999999996 109.991 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.09 -47.01 54.02 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.373 -0.603 . . . . 2.0800000000000001 109.373 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -70.2 -33.53 71.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.429 -0.805 . . . . 2.8999999999999999 109.357 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.723 HG12 ' O ' ' B' ' 30' ' ' LEU . 0.4 OUTLIER -60.52 -41.1 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.905 -0.589 . . . . 1.2 109.964 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.694 ' HB1' HD11 ' C' ' 37' ' ' LEU . . . -67.25 -34.18 76.91 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.498 -0.556 . . . . 0.72999999999999998 109.498 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -60.32 -48.89 79.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.769 -0.651 . . . . 3.0099999999999998 110.35 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.82 -38.82 92.51 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.209 -0.663 . . . . 2.1299999999999999 109.209 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.673 HD11 ' HB1' ' A' ' 34' ' ' ALA . 34.0 mt -62.49 -47.89 82.0 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.597 -0.89 . . . . 0.80000000000000004 108.597 178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ASN . . . . . 0.588 ' HA ' ' HG ' ' B' ' 41' ' ' LEU . 0.1 OUTLIER -54.11 -32.44 55.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.151 -0.931 . . . . 1.6899999999999999 110.749 178.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.457 ' O ' HG13 ' B' ' 42' ' ' ILE . 5.1 tt0 -62.22 -57.07 12.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 2.6200000000000001 110.016 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.543 ' O ' HD22 ' A' ' 44' ' ' LEU . 12.5 m -52.92 -31.06 38.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.306 0.574 . . . . 1.3400000000000001 109.977 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.768 ' CD2' HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -71.44 -25.58 62.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.717 -0.674 . . . . 0.83999999999999997 110.259 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.502 HG13 ' N ' ' B' ' 43' ' ' ASP . 1.0 OUTLIER -67.51 -31.91 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.744 -1.206 . . . . 2.1699999999999999 107.744 177.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.502 ' N ' HG13 ' B' ' 42' ' ' ILE . 0.1 OUTLIER -61.39 -58.93 6.24 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 114.798 -1.092 . . . . 1.8 109.979 178.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.849 HD12 ' N ' ' B' ' 45' ' ' GLN . 4.2 pp -53.4 -32.79 51.17 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.236 -0.438 . . . . 1.8 110.603 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . 0.849 ' N ' HD12 ' B' ' 44' ' ' LEU . 5.8 mt-30 -62.6 -38.55 90.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 2.6899999999999999 110.137 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -84.69 -29.83 25.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.842 -0.617 . . . . 2.9100000000000001 110.505 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.41 HD11 ' O ' ' A' ' 44' ' ' LEU . 33.2 mt -58.17 -34.87 70.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.035 -0.53 . . . . 1.1200000000000001 110.682 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.86 9.12 63.8 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.777 -0.725 . . . . 1.3999999999999999 112.797 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -99.29 -74.75 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.893 0.378 . . . . 3.8700000000000001 111.176 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -100.21 -36.16 9.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.142 -0.481 . . . . 5.9100000000000001 111.14 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -52.83 -31.87 41.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 4.96 111.327 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.98 15.0 21.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.431 -0.35 . . . . 4.3499999999999996 111.34 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -59.95 -24.11 64.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.802 0.334 . . . . 6.7199999999999998 110.775 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.681 ' O ' HD13 ' C' ' 54' ' ' ILE . 7.0 pt -71.39 130.69 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 4.0599999999999996 111.007 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.444 ' HA ' HG21 ' C' ' 54' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 9.1899999999999995 110.911 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.493 -0.243 . . . . 12.26 112.493 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -174.91 -74.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 11.210000000000001 110.879 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' HIS . . . . . 0.464 ' HB3' HG23 ' B' ' 4' ' ' THR . 21.4 m-70 -88.43 88.89 7.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 8.5099999999999998 110.844 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' THR . . . . . 0.464 HG23 ' HB3' ' A' ' 3' ' ' HIS . 4.1 m -102.84 159.62 15.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 7.6699999999999999 110.886 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 19.6 p -127.27 138.97 33.88 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 4.8399999999999999 110.948 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.64 -165.05 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.568 2.179 . . . . 3.4399999999999999 112.207 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -87.13 111.99 21.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 5.1799999999999997 110.504 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' VAL . . . . . 0.655 HG13 ' O ' ' C' ' 8' ' ' VAL . 8.7 p -91.18 92.01 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 2.7999999999999998 111.341 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' ASP . . . . . 0.735 ' O ' HG23 ' C' ' 13' ' ' ILE . 51.2 m-20 -94.39 98.2 10.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.007 -0.542 . . . . 3.9500000000000002 110.394 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' LEU . . . . . 0.711 HD13 ' HB ' ' A' ' 13' ' ' ILE . 1.5 pp -78.02 -31.47 50.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.309 -0.405 . . . . 3.4100000000000001 111.072 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.88 -12.81 82.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.64 -0.791 . . . . 1.8 112.612 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -103.82 -44.35 5.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.64 0.257 . . . . 3.3399999999999999 111.219 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.735 HG23 ' O ' ' C' ' 9' ' ' ASP . 1.4 pp -56.43 -32.85 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.776 0.322 . . . . 1.8300000000000001 111.399 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -69.26 -77.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 1.5700000000000001 110.651 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.98 5.73 53.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.98 -0.628 . . . . 1.4199999999999999 113.026 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.694 HG12 HD11 ' B' ' 16' ' ' ILE . 2.6 pp -96.18 -17.87 6.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.753 0.277 . . . . 2.04 111.522 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -48.71 -49.53 37.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.862 0.363 . . . . 2.5800000000000001 110.902 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -30.88 71.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 1.73 110.706 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 67.3 m -72.55 -40.85 66.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 1.75 110.671 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' VAL . . . . . 0.623 HG23 ' O ' ' C' ' 16' ' ' ILE . 15.9 t -56.82 -49.13 79.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 1.6599999999999999 110.923 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 30.0 t -63.19 -41.2 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 2.1899999999999999 110.641 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.45 -51.28 69.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.972 -0.558 . . . . 2.4500000000000002 110.964 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.503 HG22 ' O ' ' C' ' 20' ' ' VAL . 6.9 tp -60.93 -35.3 63.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.318 -0.401 . . . . 1.6499999999999999 110.625 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -61.57 -52.81 62.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 2.3999999999999999 110.145 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -23.78 67.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.569 . . . . 4.6799999999999997 110.425 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' GLU . . . . . 0.6 ' HB3' HD13 ' B' ' 27' ' ' ILE . 2.1 tt0 -67.12 -51.86 48.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 2.3999999999999999 110.24 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' ILE . . . . . 0.872 ' HA ' HD11 ' B' ' 27' ' ' ILE . 1.0 OUTLIER -57.42 -42.66 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 109.827 -0.434 . . . . 0.93000000000000005 109.827 179.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ASP . . . . . 0.414 ' N ' ' CG2' ' C' ' 27' ' ' ILE . 0.4 OUTLIER -54.07 -34.4 60.02 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.848 -0.797 . . . . 2.23 108.848 178.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -65.85 -36.87 84.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.303 -0.862 . . . . 3.6299999999999999 109.938 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' LEU . . . . . 0.699 ' O ' HG12 ' C' ' 33' ' ' VAL . 13.3 mt -79.65 -41.84 26.1 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 109.945 -0.391 . . . . 0.94999999999999996 109.945 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -46.98 53.86 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.404 -0.591 . . . . 2.0800000000000001 109.404 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -70.24 -33.47 71.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.421 -0.809 . . . . 2.8999999999999999 109.325 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.699 HG12 ' O ' ' C' ' 30' ' ' LEU . 0.4 OUTLIER -60.61 -41.01 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.926 -0.579 . . . . 1.1899999999999999 109.973 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' ALA . . . . . 0.671 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -67.24 -34.18 76.91 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.522 -0.548 . . . . 0.72999999999999998 109.522 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -60.38 -48.83 80.07 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.739 -0.664 . . . . 3.0099999999999998 110.333 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.76 -38.88 92.75 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.234 -0.654 . . . . 2.1299999999999999 109.234 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' LEU . . . . . 0.694 HD11 ' HB1' ' B' ' 34' ' ' ALA . 33.8 mt -62.47 -47.9 81.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.622 -0.881 . . . . 0.80000000000000004 108.622 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.597 ' HA ' ' HG ' ' C' ' 41' ' ' LEU . 0.1 OUTLIER -54.1 -32.39 54.79 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.146 -0.934 . . . . 1.6899999999999999 110.811 178.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.468 ' O ' HG13 ' C' ' 42' ' ' ILE . 5.1 tt0 -62.21 -57.08 12.78 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.834 -0.621 . . . . 2.6200000000000001 110.045 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.547 ' O ' HD22 ' B' ' 44' ' ' LEU . 12.4 m -52.92 -31.1 38.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.987 -0.551 . . . . 1.3400000000000001 109.922 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' LEU . . . . . 0.767 ' CD2' HD22 ' B' ' 41' ' ' LEU . 0.5 OUTLIER -71.42 -25.55 62.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.707 -0.679 . . . . 0.83999999999999997 110.289 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . 0.502 HG13 ' N ' ' C' ' 43' ' ' ASP . 1.0 OUTLIER -67.51 -31.97 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 107.728 -1.212 . . . . 2.1699999999999999 107.728 177.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.502 ' N ' HG13 ' C' ' 42' ' ' ILE . 0.1 OUTLIER -61.33 -58.94 6.21 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.811 -1.086 . . . . 1.8 109.957 178.14 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.854 HD12 ' N ' ' C' ' 45' ' ' GLN . 4.2 pp -53.48 -32.75 51.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.211 -0.449 . . . . 1.8 110.589 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' GLN . . . . . 0.854 ' N ' HD12 ' C' ' 44' ' ' LEU . 5.8 mt-30 -62.57 -38.61 90.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 2.6899999999999999 110.135 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -84.68 -29.78 25.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.602 . . . . 2.9100000000000001 110.483 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' LEU . . . . . 0.407 HD11 ' O ' ' B' ' 44' ' ' LEU . 33.0 mt -58.29 -34.82 70.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.107 -0.497 . . . . 1.1200000000000001 110.641 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.89 9.18 63.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.72 . . . . 1.3999999999999999 112.81 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -99.31 -74.68 0.58 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.839 0.352 . . . . 3.8700000000000001 111.216 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -100.2 -36.21 9.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.144 -0.48 . . . . 5.9100000000000001 111.143 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -52.87 -31.87 41.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 4.96 111.313 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.91 14.95 21.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.428 -0.351 . . . . 4.3600000000000003 111.363 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -59.87 -24.18 64.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.845 0.355 . . . . 6.7199999999999998 110.803 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ILE . . . . . 0.681 ' O ' HD13 ' A' ' 54' ' ' ILE . 6.9 pt -71.41 130.73 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 4.0599999999999996 110.986 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' LYS . . . . . 0.442 ' HA ' HG21 ' A' ' 54' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.245 -0.883 . . . . 9.1899999999999995 110.884 -179.936 . . . . . . . . 2 2 . 1 stop_ save_